Drug Type Small molecule drug |
Synonyms metabotropic glutamate receptor stimulator (Tokyo Metro), F-2-CCG-I |
Target |
Action modulators |
Mechanism mGluRs modulators(Metabotropic glutamate receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Craniocerebral Trauma | Discovery | Japan | - | |
| Epilepsy | Discovery | Japan | - | |
| Neurodegenerative Diseases | Discovery | Japan | - |





